Neuralink 开始 CAN-PRIME 研究，这是其完全植入式 BCI 的首次国际试验

这家埃隆·马斯克支持的 BCI 制造商现在可以开始 CAN-PRIME 研究，这是其首次国际试验。它以美国正在进行的 PRIME 研究为基础，评估该公司的完全植入式无线 BCI

Elon Musk-backed brain-computer interface (BCI) company Neuralink has announced the launch of its first international clinical trial, named CAN-PRIME. The study will evaluate the safety and efficacy of the company's fully implantable, wireless BCI device in Canadian residents with limited or no ability to use both hands.

埃隆·马斯克 (Elon Musk) 支持的脑机接口 (BCI) 公司 Neuralink 宣布启动首个国际临床试验，名为 CAN-PRIME。该研究将评估该公司完全植入式无线 BCI 设备对双手使用能力有限或无能力的加拿大居民的安全性和有效性。

The CAN-PRIME study builds upon the ongoing PRIME study in the U.S., which is investigating the use of Neuralink's BCI in people with quadriplegia. The study will assess the initial functionality of the BCI, called Telepathy, in enabling participants to control external devices with their thoughts.

CAN-PRIME 研究建立在美国正在进行的 PRIME 研究的基础上，该研究正在调查 Neuralink 的 BCI 在四肢瘫痪患者中的使用情况。该研究将评估脑机接口（BCI）的初始功能（称为心灵感应），使参与者能够用他们的思想控制外部设备。

The study is open to Canadian residents who have sustained a cervical spinal cord injury or have been diagnosed with amyotrophic lateral sclerosis (ALS), rendering them with limited or no ability to use both hands.

这项研究向患有颈脊髓损伤或被诊断患有肌萎缩侧索硬化症（ALS）、导致双手使用能力有限或无法使用的加拿大居民开放。

"This study marks an important step towards developing innovative BCI technology that has the potential to transform the lives of individuals with neurological disorders around the world," Neuralink said in a statement.

Neuralink 在一份声明中表示：“这项研究标志着开发创新脑机接口技术的重要一步，该技术有可能改变世界各地神经系统疾病患者的生活。”

Neuralink, founded by Musk in 2016, is among several companies and research institutions worldwide striving to advance BCI technology.

Neuralink 由马斯克于 2016 年创立，是全球多家致力于推进 BCI 技术的公司和研究机构之一。

The company's implant, unveiled during a livestreamed event in January, is designed to be wirelessly charged and boasts electrode-laced threads that can be inserted deeper into the brain. Neuralink also boasts a specialized R1 robot, crafted to implant the BCI system while navigating around vasculature.

该公司的植入物在一月份的一次直播活动中推出，设计为无线充电，并拥有可以插入大脑更深处的电极线。 Neuralink 还拥有一款专门的 R1 机器人，专门用于在血管系统周围导航时植入 BCI 系统。

According to analysts, the total addressable market (TAM) for BCI technology in the U.S. alone is valued at approximately $400 billion. The technology holds immense promise in enhancing the quality of life for individuals with neurological disorders, ranging from paralysis to blindness and deafness.

据分析师称，仅在美国 BCI 技术的总潜在市场 (TAM) 价值就约为 4000 亿美元。该技术在提高患有神经系统疾病（从瘫痪到失明和耳聋）的患者的生活质量方面具有巨大的前景。

Earlier this year, Neuralink showcased the first human implant of its BCI device, with a nine-minute livestream demonstration revealing Noland Arbaugh using the implant to move a computer cursor and play chess online. The company also announced plans for another human implant this past summer.

今年早些时候，Neuralink 展示了其脑机接口设备的首个人体植入物，通过九分钟的直播演示，诺兰·阿博 (Noland Arbaugh) 使用该植入物移动计算机光标并在线下棋。该公司还在去年夏天宣布了另一个人体植入物的计划。